Entity Common Stock, Shares Outstanding of CytoDyn Inc. from 17 Jan 2012 to 31 Dec 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
CytoDyn Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 17 Jan 2012 to 31 Dec 2025.
  • CytoDyn Inc. Entity Common Stock, Shares Outstanding for the quarter ending 31 Dec 2025 was 1,270,395,000, a 3.4% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

CytoDyn Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 1,270,395,000 +42,163,000 +3.4% 31 Dec 2025 10-Q 09 Jan 2026 2026 Q2
Q3 2025 1,259,753,000 +39,911,000 +3.3% 30 Sep 2025 10-Q 10 Oct 2025 2026 Q1
Q2 2025 1,251,534,000 +36,634,000 +3% 30 Jun 2025 10-K 25 Jul 2025 2025 FY
Q1 2025 1,232,433,000 +239,067,000 +24% 31 Mar 2025 10-Q 14 Apr 2025 2025 Q3
Q4 2024 1,228,232,000 +248,705,000 +25% 31 Dec 2024 10-Q 14 Jan 2025 2025 Q2
Q3 2024 1,219,842,000 +288,690,238 +31% 30 Sep 2024 10-Q 15 Oct 2024 2025 Q1
Q2 2024 1,214,900,000 31 Jul 2024 10-K/A 30 Sep 2024 2024 FY
Q1 2024 993,366,000 +80,852,948 +8.9% 31 Mar 2024 10-Q 15 Apr 2024 2024 Q3
Q4 2023 979,527,000 +146,556,290 +18% 31 Dec 2023 10-Q 16 Jan 2024 2024 Q2
Q3 2023 931,151,762 +118,326,545 +15% 30 Sep 2023 10-Q 23 Oct 2023 2024 Q1
Q1 2023 912,513,052 +194,193,446 +27% 31 Mar 2023 10-Q 10 Apr 2023 2023 Q3
Q4 2022 832,970,710 +142,737,206 +21% 31 Dec 2022 10-Q 09 Jan 2023 2023 Q2
Q3 2022 812,825,217 +152,633,665 +23% 30 Sep 2022 10-Q/A 13 Oct 2022 2023 Q1
Q2 2022 810,720,424 +178,133,547 +28% 31 Jul 2022 10-K 15 Aug 2022 2022 FY
Q1 2022 718,319,606 +105,444,382 +17% 31 Mar 2022 10-Q 11 Apr 2022 2021 Q3
Q4 2021 690,233,504 +92,100,638 +15% 31 Dec 2021 10-Q 10 Jan 2022 2021 Q2
Q3 2021 660,191,552 +89,440,503 +16% 30 Sep 2021 10-Q 12 Oct 2021 2021 Q1
Q2 2021 632,586,877 +64,344,486 +11% 15 Jul 2021 10-K/A 28 Sep 2021 2021 FY
Q1 2021 612,875,224 +130,700,817 +27% 31 Mar 2021 10-Q 14 Apr 2021 2020 Q3
Q4 2020 598,132,866 +167,377,094 +39% 31 Dec 2020 10-Q 08 Jan 2021 2020 Q2
Q3 2020 570,751,049 +182,496,853 +47% 30 Sep 2020 10-Q 09 Oct 2020 2020 Q1
Q2 2020 568,242,391 +203,493,828 +56% 31 Jul 2020 10-K 14 Aug 2020 2020 FY
Q1 2020 482,174,407 +176,684,313 +58% 31 Mar 2020 10-Q 09 Apr 2020 2020 Q3
Q4 2019 430,755,772 +137,832,291 +47% 31 Dec 2019 10-Q 09 Jan 2020 2020 Q2
Q3 2019 388,254,196 +132,491,247 +52% 04 Oct 2019 10-Q 08 Oct 2019 2020 Q1
Q2 2019 364,748,563 +146,055,784 +67% 30 Jun 2019 10-K 14 Aug 2019 2019 FY
Q1 2019 305,490,094 +93,407,315 +44% 31 Mar 2019 10-Q 09 Apr 2019 2019 Q3
Q4 2018 292,923,481 +123,062,023 +72% 31 Dec 2018 10-Q 09 Jan 2019 2019 Q2
Q3 2018 255,762,949 +99,663,375 +64% 28 Sep 2018 10-Q 09 Oct 2018 2019 Q1
Q2 2018 218,692,779 +65,929,536 +43% 30 Jun 2018 10-K 27 Jul 2018 2018 FY
Q1 2018 212,082,779 +62,614,535 +42% 31 Mar 2018 10-Q 09 Apr 2018 2018 Q3
Q4 2017 169,861,458 +27,639,477 +19% 31 Dec 2017 10-Q 08 Jan 2018 2018 Q2
Q3 2017 156,099,574 +17,877,593 +13% 30 Sep 2017 10-Q 10 Oct 2017 2018 Q1
Q2 2017 152,763,243 +28,229,138 +23% 30 Jun 2017 10-K 20 Jul 2017 2017 FY
Q1 2017 149,468,244 +31,095,969 +26% 31 Mar 2017 10-Q 13 Apr 2017 2017 Q3
Q4 2016 142,221,981 +43,284,551 +44% 31 Dec 2016 10-Q 13 Jan 2017 2017 Q2
Q3 2016 138,221,981 +54,522,348 +65% 30 Sep 2016 10-Q 12 Oct 2016 2017 Q1
Q2 2016 124,534,105 +54,391,773 +78% 30 Jun 2016 10-K 19 Jul 2016 2016 FY
Q1 2016 118,372,275 +54,932,080 +87% 31 Mar 2016 10-Q 13 Apr 2016 2016 Q3
Q4 2015 98,937,430 +40,203,955 +68% 31 Dec 2015 10-Q 11 Jan 2016 2016 Q2
Q3 2015 83,699,633 +27,947,130 +50% 30 Sep 2015 10-Q 09 Oct 2015 2016 Q1
Q2 2015 70,142,332 +14,389,021 +26% 30 Jun 2015 10-K 10 Jul 2015 2015 FY
Q1 2015 63,440,195 +7,871,814 +14% 31 Mar 2015 10-Q 10 Apr 2015 2015 Q3
Q4 2014 58,733,475 +3,397,454 +6.1% 31 Dec 2014 10-Q 12 Jan 2015 2015 Q2
Q3 2014 55,752,503 +16,123,316 +41% 30 Sep 2014 10-Q 10 Oct 2014 2014 Q1
Q2 2014 55,753,311 +24,955,161 +81% 30 Jun 2014 10-K 10 Jul 2014 2014 FY
Q1 2014 55,568,381 +24,675,232 +80% 31 Mar 2014 10-Q 11 Apr 2014 2014 Q3
Q4 2013 55,336,021 +25,319,672 +84% 31 Dec 2013 10-Q 13 Jan 2014 2014 Q2
Q3 2013 39,629,187 +9,730,626 +33% 30 Sep 2013 10-Q 15 Oct 2013 2014 Q1
Q2 2013 30,798,150 +1,586,641 +5.4% 31 Jul 2013 10-K 29 Aug 2013 2013 FY
Q1 2013 30,893,149 +2,424,535 +8.5% 01 Apr 2013 10-Q 12 Apr 2013 2013 Q3
Q4 2012 30,016,349 +7,725,367 +35% 03 Jan 2013 10-Q 14 Jan 2013 2013 Q2
Q3 2012 29,898,561 30 Sep 2012 10-Q/A 08 Nov 2012 2013 Q1
Q2 2012 29,211,509 31 Jul 2012 10-K 22 Aug 2012 2012 FY
Q1 2012 28,468,614 01 Apr 2012 10-Q 16 Apr 2012 2012 Q3
Q4 2011 22,290,982 17 Jan 2012 10-Q 17 Jan 2012 2012 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.